Basolateral Amygdala Reactive Microglia May Contribute to Synaptic Impairment and Depressive-Like Behavior in Mice

Li Jiang1, Jing Hao1, Xu-Li Yang1

  • 1Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, 321 Zhongshan Road, Nanjing, 210008, China.

Neurochemical Research
|August 24, 2022
PubMed

Insights

Cancer pain triggers depression by causing microglia to engulf synapses in the basolateral amygdala (BLA). Inhibiting microglia reduced depressive behavior and synaptic loss, suggesting a new therapeutic target for cancer pain-induced depression.

Area of Science:

  • Neuroscience
  • Oncology
  • Immunology

Background:

  • Cancer-related pain significantly impacts patient quality of life and survival by inducing anxiety and depression.
  • The basolateral amygdala (BLA), a key limbic system component, processes negative emotions, and its dysfunction is linked to depression.
  • Microglial engulfment of synapses is implicated in adolescent depression, but its role in cancer pain-induced depression is unknown.

Purpose of the Study:

  • To investigate the link between dendritic spine synapses, depressive-like behavior, and microglial function in the BLA of a bone cancer pain model.
  • To explore the role of microglia-mediated synaptic loss in the pathology of cancer pain-induced depression.

Main Methods:

  • Establishment of a bone cancer pain mouse model.
  • Assessment of depressive-like behavior in tumor-bearing mice.
  • Investigation of microglial activity and synaptic changes within the BLA.
  • Administration of the microglial inhibitor minocycline.

Main Results:

  • Tumor-bearing mice exhibited depressive-like behavior and pain.
  • Reactive microglia and phagocytic synapses were observed in the BLA of these mice.
  • Minocycline treatment alleviated depressive behavior, reduced synaptic damage, and decreased microglial phagocytic activity.

Conclusions:

  • Microglia-mediated synaptic loss in the BLA is a key pathological mechanism underlying depressive-like behavior in bone cancer pain.
  • Targeting microglial function presents a potential therapeutic strategy for managing depression associated with cancer pain.

Related Concept Videos